Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference14 articles.
1. Andreotti F, Rocca B, Husted S, et al. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. Eur Heart J. 2015;36:3238–49.
2. Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–5.
3. Taggar JS, Lip GYH. Anticoagulation for elderly patients with atrial fibrillation: not to be neglected. Europace. 2008;10:1–2.
4. Zarraga IGE, Kron J. Oral anticoagulation in elderly adults with atrial fibrillation: integrating new options with old concepts. J Am Geriatr Soc. 2013;61:143–50.
5. Lai C-L, Chen H-M, Liao M-T, Lin T-T. Dabigatran, rivaroxaban, and warfarin in the oldest adults with atrial fibrillation in Taiwan. J Am Geriatr Soc. 2018;66:1567–74.